Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2025-06-12 to 2025-06-23
Current total value of award: $12981.22
Description: 8511439785!TYPHOID VI POLYSACC